This is evident from the severe clinical phenotypes of patients lacking either enzyme: ADA1 deficiency causes severe lymphopenia (ADA–severe combined immunodeficiency) as a result of intracellular accumulation of toxic purine metabolites.17 Here, ADA is linked to combined immunodeficiency.